Impact of Osteoporotic Fracture Type and Subsequent Fracture on Mortality: The Tromsø Study by Alarkawi, Dunia et al.
 1
Impact of Osteoporotic Fracture Type and Subsequent Fracture on Mortality: The 
Tromsø Study 
 
Dunia Alarkawi 1, Dana Bliuc 1, Thach Tran 1, Luai A Ahmed 2, Nina Emaus 3, Åshild 
Bjørnerem 4,5, Lone Jørgensen 3, Tore Christoffersen 3,6, John A Eisman 1,7,8,9, Jacqueline R 
Center 1,7,8 
1. Bone Biology Division, Garvan Institute of Medical Research, Sydney, Australia 
2. Institute of Public Health, United Arab Emirates University, Al Ain, UAE 
3. Department of Health and Care Sciences, UiT The Arctic University of Norway, 
Tromsø, Norway 
4. Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, 
Norway 
 
5. Department of Obstetrics and Gynecology, University Hospital of North Norway, 
Tromsø, Norway 
 
6. Finnmark Hospital Trust, Hammerfest, Norway 
 
7. Faculty of Medicine, University of New South Wales, Sydney, Australia 
8. Clinical School, St Vincent’s Hospital, Sydney, Australia 
9. School of Medicine Sydney, University of Notre Dame, Sydney, Australia 
Corresponding author: 
Dunia Alarkawi 
Address: Garvan Institute of Medical Research,  
   384 Victoria St Darlinghurst  
   NSW 2010 Australia 
Email: dunia.ark@gmail.com 




Less is known about the impact of non-hip non-vertebral fractures (NHNV) on early death. 
This study demonstrated increased risk of dying following hip and NHNV fractures which 
was further increased by a subsequent fracture. This highlights the importance of early 






Introduction: Osteoporotic fractures are a major health concern. Limited evidence exists on 
their impact on mortality in ageing populations. This study examined the contribution of 
initial fracture type and subsequent fracture on mortality in a Norwegian population that has 
one of the highest rates of fractures. 
Methods: The Tromsø Study is a prospective population-based cohort in Norway. Women 
and men aged 50+ years were followed from 1994 to 2010. All incident hip and non-hip non-
vertebral fractures (NHNV) were registered. NHNV fractures were classified as either 
proximal or distal. Information on self-reported co-morbidities, lifestyle factors, general 
health and education level was collected. Multivariable Cox models were used to quantify 
mortality risk with incident and subsequent fractures analysed as time-dependent variables.  
Results: Of 5,214 women and 4,620 men, 1,549 (30%) and 504 (11%) sustained a fracture, 
followed by 589 (38%) and 254 (51%) deaths over 10,523 and 2,821 person-years, 
respectively. There were 403 (26%) subsequent fractures in women and 68 (13%) in men. 
Hip fracture was associated with a two-fold increase in mortality risk (HR 2.05, 95% CI 1.73-
2.42 in women, and 2.49, 95% CI 2.00-3.11 in men). Proximal NHNV fractures were 
associated with 49% and 81% increased mortality risk in women and men (HR 1.49 95% CI 
1.21-1.84 and 1.81 95% CI 1.37-2.41), respectively. Distal NHNV fractures were not 
associated with mortality. Subsequent fracture was associated with 89% and 77% increased 
mortality risk in women and men (HR 1.89 95%CI 1.52-2.35 and 1.77 95%CI 1.16-2.71), 
respectively. 
Conclusion: Hip, proximal NHNV and subsequent fractures were significantly associated 




Osteoporotic fractures are a major and increasing cause of morbidity and loss of 
independence worldwide with an annual global loss of 5.8 million healthy life years to 
disability (1). It has been demonstrated that following an osteoporotic fracture the risk of a 
subsequent fracture increases by at least two-fold (2-5). Moreover, multiple studies have 
demonstrated an association between hip and vertebral fractures and increased risk of 
mortality (6-12). There is also growing evidence about the contribution of non-hip non-
vertebral fractures (NHNV), the largest group of osteoporotic fractures, to increased mortality 
risk (12-17). In addition, there is evidence that subsequent fractures are associated with 
further increased risk of mortality (8, 18).  
Norway has one of the highest hip fracture rates in the world (19-21). A systematic review of 
63 countries presented a ten-fold variation in hip fracture risk and a ten-year probability of a 
major osteoporotic fracture worldwide with Denmark, Sweden and Norway exhibiting the 
highest rates (22). The reasons for this variation in fracture incidence are unknown. However, 
genetic and environmental factors are thought to play an important role (23).  
In Norway, the increased risk of a subsequent fracture after initial fracture and the increased 
mortality risk following hip fracture has been well explored (5, 24-26). However, the impact 
of NHNV fractures and subsequent fractures following initial fractures on mortality have not 
been thoroughly examined. In a country with one of the highest life expectancies in the world 
and where osteoporotic fracture risk is on the rise with its ageing population, it is important to 
further explore and quantify the association with mortality of osteoporotic fractures and re-
fracture, as potentially modifiable factors.  
Therefore, based on data from Norway, the aims of this study were to examine the specific 
contribution of initial hip and NHNV fractures and subsequent fractures on mortality risk. 
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Methods 
Study population and design 
The Tromsø Study is a prospective, population-based cohort study in Tromsø, the largest city 
in Northern Norway. The study consists of seven health surveys (Tromsø 1-7) with Tromsø 1 
being initiated in 1974 and Tromsø 7 completed in 2016. Participants were asked to complete 
questionnaires, which were supplemented by a short interview and a medical examination 
(27, 28). In this study, data collected in Tromsø 4 (1994/95) were used. Tromsø 4 is the 
largest survey. It included a total of 27,158 people (12,865 men and 14,293 women in the 25-
97 age range). This study included the 5,214 women and 4,620 men from Tromsø 4 who 
were aged 50 years and older. The period extended from 1994-1995 to the end of 2010. Study 
participants were followed up until the end of the study or until they died.  
Fracture and mortality data ascertainment  
Fracture events were identified from the fracture registry, which is based on the radiographic 
archives at the University Hospital of North Norway in Tromsø. The computerized records 
in the radiographic archives contain the national personal identification number, date of the 
fracture, fracture codes and descriptions. All radiographic examinations coded “abnormal” 
for participants in Tromsø 4 were reviewed to ascertain the fracture code, to identify the 
exact fracture type, its mechanism of injury (high trauma e.g.: motor vehicle accidents, 
pathological fractures e.g.: cancers or minimal trauma e.g. bumps, strains and falling from 
standing height) and anatomical location, to distinguish consecutive fracture cases from one 
another and to capture any fractures that may have not been coded correctly (29, 30).  
The current study included only minimal trauma fractures, which occurred following a fall 
from standing height or less. High trauma fractures, pathological fractures as well as 
fractures of the head, fingers and toes were excluded. Incident fractures were analysed 
according to fracture type as hip and NHNV. NHNV were classified as either proximal 
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(pelvis, humerus, clavicle, femur, scapula, ribs and sternum) or distal (radius, ulna, tibia, 
fibula, hand and foot). Vertebral fractures were not included in this study as they were not 
systematically collected. Mortality status was ascertained from the Population Register of 
Norway to which the Tromsø study is linked.  
Clinical characteristics 
Information was obtained from the self-administered questionnaires and physical 
examinations and included: age, body mass index (BMI), self-reported prior hip/forearm 
fractures, comorbidities (cardiovascular diseases, stroke, asthma, diabetes and 
hypertension), marital status [married/(single, divorced or widowed)], general health 
condition (good/poor), education level (junior high school, senior high school and 
college/university degree) and lifestyle factors such as smoking (yes/no), alcohol intake 
(yes/no) and hard physical activity (1 hour/week and 1 hour/week). 
Statistical analysis  
Statistical analyses were performed using SAS, version 9.4. 
Fracture and subsequent fracture were analysed as time-dependent variables, such that in the 
whole cohort fractured participants were considered in the no-fracture group until they had 
their first fracture at which point, they were followed up till the end of the study as the 
fracture group and in the fractured cohort those who had a subsequent fracture were 
considered in the no-subsequent fracture group until they had their subsequent fracture. Age 
was analysed as a time-dependent variable representing age at first fracture for those with 
only one fracture and age at subsequent fracture for those who experienced a subsequent 
fracture. Co-morbidities were not analysed as time-dependent variables and represented 
baseline information for those with single fractures and those with subsequent fractures. 
Gender-specific crude mortality rates per 100 person-years were calculated for the whole 
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cohort for the overall period of follow up and at different time intervals (0-1, 1-2, 2-5 and 
>5). Age-standardised mortality ratios (SMRs) were calculated for the fracture group by 
comparing age and gender-specific mortality rates for each fracture type (hip and proximal 
and distal NHNV) with the age and gender-specific mortality rates for the no-fracture group. 
SMRs were also calculated for the whole follow-up period as well as for different time 
intervals (0-1, 1-2, 2-5 and >5 years post-fracture). The main reason for calculating SMRs 
was to estimate the change in mortality risks post-fracture over different time intervals. This 
analysis was unable to be performed using the Cox proportional hazards models (used in all 
other analyses) as the time-dependent Cox model which estimate risks at different time 
intervals could not handle the time-varying variable (fracture) that changes over time. The 
mortality rates and SMRs and their 95% confidence intervals were estimated assuming a 
Poisson distribution.  
The association between fracture, subsequent fracture and mortality was examined in two 
ways: 1) in the whole cohort: the contribution of initial fracture type over and above other 
predefined risk factors on mortality risk was compared to the no-fracture group, and 2) in the 
fractured cohort: the contribution of subsequent fractures on post-fracture mortality after 
adjusting for risk factors was compared to the group with the lowest mortality risk derived 
from the adjusted survival curves. The reference group was those with a distal NHNV fracture 
and no subsequent fracture. The additional effect of subsequent fracture on post-fracture 
mortality for each fracture type was estimated by simply subtracting the hazard ratios for 
those with a single fracture only from those with a subsequent fracture. To further explore the 
significance of the additional effect of subsequent fracture, an additional analysis involving a 
direct comparison between those with a subsequent fracture versus those with a single fracture 
stratified by gender and fracture type was performed i.e. those with single hip fracture 
(referent group) versus hip fracture + subsequent fracture. 
 8
Cox proportional hazards models were used to quantify mortality risk by calculating hazard 
ratios (HRs) and 95% confidence intervals (CIs) after adjusting for potential confounders 
(listed above). The proportional hazards assumptions for Cox models were tested for using 
Schoenfeld residuals for the time-dependent variables, Kaplan Meier curves for the 
categorical variables and Martingale residuals for continuous variables.  
Population impact number (PIN) and case impact number (CIN) which are measures that 
reflect the impact of osteoporotic fractures on mortality in the whole study population were 
calculated. PIN is the number of those in the whole population amongst whom one death is 
attributable to fracture. CIN is the number of those who died amongst whom one case is 
attributable to fracture (31). Those measures were calculated as a function of the hazard 
ratios, prevalence of fracture, and incidence rate of mortality and their 95% CIs were 
calculated using the confidence limits of the adjusted hazard ratios. Impact measures were 
not computed for a statistically non-significant association between fracture and mortality 
(31). 
Results 
The study included 5,214 (53%) women and 4,620 (47%) men. The mean age was 64 ± 10 for 
women and 62 ± 9 years for men. The median follow-up time was 11 years (IQR, 6 to 16 
years). During the follow-up 1,758 (34%) women and 1,822 (39%) men died. In the fracture 
cohort, 589 (38%) women and 254 (51%) men died over 10,523 and 2,821 person-years, 
respectively. As expected, those who died (in both the whole cohort and fracture group) were 
significantly (p<0.05) older, had more comorbidities and poorer health status. In addition, 
they were less likely to be married, exercised less and had lower education levels (Table 1).  
Initial fracture rates, crude mortality rates and SMRs 
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There were 1,549 (30%) fractures in women and 504 (11%) in men over 60,376 and 56,632 
person-years, respectively. NHNV fractures accounted for 75% (n=1,165) of fractures in 
women and 64% (n=323) in men. The majority of the NHNV fractures were distal; 75% 
(n=874) in women and 67% (n=218) in men. Hip fracture incidence was two-fold higher in 
women then in men (6.4/1000 person-years versus 3.2/1000 person-years) and NHNV 
fracture incidence was three-fold higher in women than in men (19.3/1000 person-years 
versus 5.7/1000 person-years).  
Those with a fracture had a three-fold higher crude mortality rate compared to those with no 
fracture; in women [5.6/100 person-years (95% CI, 5.2-6.1) versus 1.9/100 person-years (95% 
CI, 1.8-2.1)] and in men [9.0/100 person-years (95% CI 8.0-10.2) versus 2.8/100 person-years 
(95% CI, 2.6-2.9)]. In general, men had higher crude mortality rates following all fracture 
types than women (Table 2).  
The SMRs for those with any fracture in both genders were significantly increased up to five 
years post-fracture. The SMRs for all fracture types were highest in the first year post-fracture 
ranging from 1.76-6.20 in women and 1.28-8.19 in men with the highest SMRs for hip 
followed by proximal NHNV followed by distal NHNV. After the first year, the SMRs 
declined progressively and after five years only hip and proximal NHNV fractures SMRs in 
women remained significant (Table 2). 
Mortality risk following initial fracture 
In both women and men, any type of fracture was associated with a 36% (HR 1.36; 95% CI, 
1.22-1.53) and a 66% (HR 1.66; 95% CI, 1.41-1.94) increased risk of mortality, respectively. 
Hip fracture was associated with the highest risk of mortality with more than two-fold 
increased risk in both genders. NHNV fractures were associated with a 15% (HR 1.15; 95% 
CI, 1.01-1.31) and a 28% (HR 1.28; 95% CI, 1.04-1.57) increase in mortality risk in women 
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and men, respectively. This excess mortality following NHNV was predominantly due to 
proximal NHNV fractures which were associated with 49% increased mortality risk in women 
(HR 1.49; 95% CI, 1.21-1.84) and 81% in men (HR 1.81; 95% CI, 1.37-2.41). Distal NHNV 
were not associated with mortality for either genders (Figure 1). 
Mortality risk following subsequent fracture 
Of 1,549 women and 504 men with incident fractures, 403 (26%) and 68 (13%) experienced a 
second fracture over a median of 6 years of follow up (IQR 2 to 9 years). The probability of 
dying over time for subjects with a single initial fracture and with an initial fracture followed 
by a subsequent fracture was presented using adjusted survival curves for Cox proportional 
hazards models. In both genders, those with distal NHNV fracture and no subsequent fracture 
had the lowest mortality probability while those with a hip fracture and a subsequent fracture 
had the highest mortality probability. For each fracture type subjects with a subsequent 
fracture had higher probability of dying compared to those with no subsequent fracture, 
particularly in women. Interestingly, women with a proximal NHNV fracture and a 
subsequent fracture appeared to have on average a similar probability of dying as women with 
a hip fracture. This effect was not observed for men (Figure 2).  
The above mortality probabilities were quantified by the following adjusted hazard ratios. 
Compared to subjects with only a distal NHNV fracture and no subsequent fracture, in women 
and men any initial fracture followed by a subsequent fracture was associated with 89% (HR 
1.89; 95% CI, 1.52-2.35) and 77% (HR 1.77; 95% CI, 1.16-2.71) increased mortality risks, 
respectively (Table 3). When analysed according to initial fracture type, a hip fracture 
followed by a subsequent fracture was associated with a three-fold higher mortality risk in 
both genders. In women, a proximal NHNV fracture followed by a subsequent fracture was 
associated with two-fold increased mortality risk while a distal NHNV fracture followed by a 
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subsequent fracture was associated with a 42% increase in mortality risk. In men, a 
subsequent fracture following proximal and distal NHNV fractures was associated with an 
increase in mortality risk, but this did not reach statistical significance, possibly due to the 
smaller number of fractures (Table 3).  
The simple difference between hazard ratios of those with a single fracture only and those 
with a subsequent fracture was performed to quantify the excess mortality risk that may be 
contributed by subsequent fractures. A subsequent fracture in women was associated with an 
increase in mortality risk by ~ 92% following a hip fracture, ~ 35% following a proximal 
NHNV fracture and ~ 42% after a distal NHNV fracture. In men, a subsequent fracture was 
associated with an increase in mortality risk by ~ 83% after a hip fracture and ~ 33% after a 
distal NHNV fracture. However, this additional risk was not seen after a proximal NHNV 
fracture which may be explained by the lower number of subsequent fractures in men in this 
group (Table 3). 
The direct comparison of a subsequent fracture versus single fracture using adjusted hazard 
ratios demonstrated that subsequent fracture was associated with 24% excess mortality in 
women but no in men. When stratified by gender and fracture type the hazard ratios were in 
general higher for subsequent fracture than initial fracture (ranging from a 1.2-1.5-fold 
increase) (Table S1). However, they were significant only for hip fracture in women. The 
non-significant higher mortality risks seen in other fracture types were still clinically 
important and the lack of significance can be explained by the smaller number of fractures in 
individual groups, such as proximal NHNV fractures in men. 
Impact of osteoporotic fractures on mortality in the population 
The PIN is the number of individuals for whom one death could be attributable to an 
osteoporotic fracture in the whole population. Calculation of the PIN indicates that in the 
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whole study population, one death would be attributable to any osteoporotic fracture for every 
373 women and 449 men. To assess the relative impact, it was useful to calculate the CIN. 
The CIN is the number of deceased individuals among whom one death would be attributable 
to an osteoporotic fracture. In this study the CIN suggested that one in 10 deaths in women 
and one in 15 deaths in men was attributable to a fracture. Hip fractures had a similar impact 
on mortality in both genders (PIN=549, CIN=15 in women and PIN=548, CIN=18 in men) 
while NHNV fractures, specifically proximal NHNV fractures, had a higher impact on 
mortality in women than in men. Those results suggest that fractures in women may have a 
higher population impact on mortality compared to men, which is related to the higher 
number of NHNV fractures in women than men. For both genders the impact of hip fractures 
on mortality was higher than the impact of all NHNV fractures (Table 4). 
Discussion  
This Norwegian study is the first to our knowledge to examine the association between 
NHNV fractures and mortality and subsequent fractures and mortality. The study 
demonstrated that proximal NHNV fractures were associated with an increased mortality risk 
of 49% in women and 81% in men in addition to the two-fold increased mortality following 
hip fractures. The highest mortality rates were seen in the first year post-fracture for both hip 
and NHNV fractures. A subsequent fracture in women and men following any initial fracture 
type was associated with 89% and 77% increased mortality risk, respectively. A subsequent 
fracture following an initial hip fracture was associated with a three-fold increase in mortality 
in both genders. However, for women only, a subsequent fracture was associated with a two-
fold increased mortality following an initial proximal NHNV fracture and by 42% following 
an initial distal NHNV fracture.  
The two-fold increased mortality risk post-hip fracture observed in this study together with 
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the findings of the highest mortality observed in the first year post-fracture, are consistent 
with other studies conducted in Norway (24-26) and internationally (6, 8, 16). The increased 
mortality risk post-NHNV fractures especially post-proximal NHNV fractures in both genders 
adds to the growing evidence of the association of NHNV fractures with mortality (8, 11, 13, 
16, 17, 32) and is the first large examination of this group of fractures in Norway. Similar to 
hip fractures, the highest mortality post-NHNV fractures was seen in the first year post-
fracture. Moreover, the lack of association between distal NHNV fractures and mortality is 
also consistent with findings from other studies (11, 13, 16, 33), although, one study 
demonstrated an increased mortality risk with minor fractures in those older than 75 years (8).  
In the Tromsø population similar to the CaMos population (16), the impact of fractures on 
mortality (PIN= 373 in women and PIN=449 in men) was greater than the impact of smoking 
on coronary-heart disease related deaths (PIN=1302) and lung-cancer related deaths 
(PIN=2564) as demonstrated by the impact measures estimated from a cohort study of British 
male physicians (31, 34). Moreover, the impact of hip fractures on mortality was greater than 
of NHNV fractures, although NHNV fractures accounted for nearly 75% of all fractures and 
were significantly associated with mortality. Those findings were in contrast to what was 
observed by Tran et al in the CaMos population (16) and may be partially explained by the 
higher incidence of hip fractures in the Tromsø cohort compared to the CaMos cohort  
(women 6.4 versus 3.5/1000 person-years and men 3.2 versus 2.6/1000 person-years, 
respectively). 
This study also demonstrated that subsequent fractures were associated with increased 
mortality risk in both women and men. The greatest impact of a subsequent fracture (three-
fold) on mortality risk was seen in those who had an initial hip fracture in both genders. 
However, in women a subsequent fracture was associated with a two-fold increase in 
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mortality risk post-proximal NHNV fracture and a 42% post-distal NHNV fracture. In men, 
there was also a consistent numerically increased mortality with subsequent fracture following 
proximal and distal NHNV fractures although this did not reach statistical significance likely 
related to the low number of subsequent fractures in men. A few studies have demonstrated an 
association between subsequent fractures and increased risk of mortality in both genders (8, 
14, 18). Bliuc et al also reported that distal NHNV fractures were associated with mortality 
only in those who sustained a subsequent fracture similar to the findings of the current study. 
Importantly, in the current study, the additive effect of subsequent fractures to mortality risk 
following the different fracture types was demonstrated in adjusted survival curves and hazard 
ratios (by direct comparison of HRs between paired fracture groups (single fracture versus 
subsequent fracture). Previous studies that explored these effects used unadjusted Kaplan 
Meier survival curves and did not take into account comorbidities or other lifestyle factors 
(14, 18).  
The mechanism of post-fracture mortality is not understood. Multiple risk factors, including 
comorbidities, have been implicated in post-hip and vertebral fractures mortality but not 
widely studied post-NHNV fractures. The role of comorbidities has been controversial with 
some studies reporting no association between comorbidities and post-fracture mortality (8, 9, 
35) and others attributing up to 50% of excess mortality post-hip and vertebral fractures to 
concomitant medical disorders especially pulmonary and cardiac diseases (36-40). A recent 
study that examined the role of comorbidities on post-NHNV fracture mortality reported that 
adjustment for comorbidities had minimal effect on the fracture-mortality relative risks, but 
comorbidities contributed independently to mortality such that a woman with a humeral 
fracture and 1 comorbidity had a similarly reduced five-year survival as that of a woman with 
a hip fracture and no comorbidities (17).  
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Recent evidence suggests that osteoporosis treatment especially bisphosphonates, which are 
known to reduce fracture risk (41), may also reduce mortality risk following osteoporotic 
fractures (42-49). Despite this, individuals with osteoporotic fractures remain undertreated, 
with less than 30% of women and less than 10% of men being treated (50-52). The poor 
management post-fracture may be due to an underestimation of the potential premature 
mortality risk following the different types of fractures. This study adds to the available 
evidence about the increased risk of mortality and subsequent fracture following different 
fracture types highlighting the importance of early treatment of osteoporotic fractures. 
The strengths of this study include the prospective design, the long follow-up and the large 
representative population. In addition, the large number of fractures in the study provided 
adequate power for the analyses of the association of fracture type with mortality and 
consequently the effect of subsequent fracture. Moreover, the availability of other collected 
variables enabled the examination of the effect of fracture on mortality over and above other 
risk factors and indicated that fracture is an independent predictor of mortality. This study has 
some limitations. Its observational nature allows finding an association but not a causal 
relation between fractures and mortality. Tromsø has few immigrants and hence the majority 
of the population are Caucasian limiting the generalisability of the findings to other ethnic 
groups. Also, as in many such studies, vertebral fractures were not registered. Nevertheless, 
the exclusion of those fractures would have only resulted in underestimation of the overall 
incident fracture and mortality rates post fracture. The misclassification would also result in 
increased mortality rates of the non-fractured population as unidentified vertebral fractures, 
known to be associated with increased mortality, would be included in the non-fractured 
population. In addition, the measures PIN and CIN, which quantify the excess mortality 
associated with fracture at a population level, are based on the assumptions that fracture has a 
direct cause on mortality. However, this study was only able to ascertain an association 
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adjusted for known variables and PIN and CIN should be viewed within this limitation. Co-
morbidities were not analysed as time-dependent variables and hence individuals with 
subsequent fracture may have had more co-morbidities by the time of second fracture which 
could pose a potential bias that may result in overestimation of the mortality risks. 
Conclusion 
In this study there was an association between hip and proximal NHNV fractures and 
increased mortality risk in both genders aged 50+ years and no association of distal NHNV 
fractures with mortality. Mortality rates following all fracture types were highest in the first 
two years post-fracture. A subsequent fracture following any fracture type, in both women 
and men was associated with an additional impact on mortality risk such that the overall 
mortality risk post-fracture was higher than in those with one fracture. This was observed 
even in those with a distal NHNV fracture. On a population-wide basis, these fractures 
contribute significantly to overall mortality. This study thus demonstrates the population-level 
impact of fracture in the elderly and support the critical need for early identification and 
management to prevent both initial and subsequent fracture and potentially improve survival. 
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Figure 1. Multivariable adjusted mortality risk by gender and fracture type in the whole 
cohort  
*Adjusted for age, BMI, comorbidities, marital status, general health condition, education level, smoking,      
alcohol intake and physical activities. 
 
 Figure 2. Adjusted survival curves for mortality probability after initial and subsequent 
fracture by gender and fracture type in the fracture cohort 
Adjusted for age, BMI, comorbidities, marital status, general health condition, education level, smoking, 
alcohol intake and physical activity. 
The distal NHNV single fracture group had the lowest death probability. The hip fracture with a subsequent    
fracture group had the highest death probability.   
Time zero corresponds to the time of initial fracture for subjects with single fracture and time of subsequent 
fracture for subjects with a subsequent fracture.   
 
Supplementary Table S1. Multivariable adjusted mortality risk following subsequent 





Table 1. Baseline characteristics of the study population 











Agea, yr 72 (9) 60 (8) 69 (9) 58 (7) 
BMI** kg/m2 26 (5) 26 (4) 26 (4) 26 (3) 
 









Cardiovascular disease 441 (25%) 234 (7%) 640 (35%) 356 (13%) 
Stroke 101 (6%) 47 (1%) 138 (8%) 42 (2%) 
Asthma 186 (11%) 240 (7%) 169 (9%) 145 (5%) 
Diabetes 144 (8%) 58 (2%) 124 (7%) 35 (1%) 











Poor health status 1158 (66%) 1589 (46%) 996 (55%) 926 (33%) 
Smoking 462 (26%) 1027 (30%) 683 (38%) 877 (31%) 
Alcohol (any) 408 (23%) 1572 (46%) 955 (52%) 1978 (71%) 
Hard Physical Activity 
hr/wk 
    
<1hr 1650 (94%) 2944 (85%) 1508 (83%) 1927 (69%) 
1hr 108 (6%) 512 (15%) 314 (17%) 871 (31%) 
Education 
    
Junior high school 1362 (77%) 2021 (59%) 1025 (56%) 1128 (40%) 
Senior high school 315 (18%) 908 (26%) 584 (32%) 929 (33%) 
College/University 
 
81 (5%) 527 (15%) 213 (12%) 741 (27%) 
Fracture group n=1549 (30%) n=504 (11%)  
n=589 (38%) n=960 (62%) n=254 (51%) n=250 (49%) 
Age, yr 74 (8) 62 (8) 71 (9) 60 (7) 
BMI**kg/m2 26 (5) 26 (4) 25 (4) 26 (3) 
     
Prior hip/forearm fracture 208 (35%) 256 (27%) 42 (17%) 39 (16%) 
Cardiovascular disease 114 (19%) 77 (8%) 78 (31%) 33 (13%) 
Stroke 37 (6%) 15 (2%) 23 (9%) 8 (4%) 
Asthma 56 (10%) 66 (7%) 20 (8%) 10 (4%) 
Diabetes 45 (8%) 15 (2%) 16 (6%) 4 (2%) 











Poor health status 370 (63%) 435 (45%) 128 (50%) 94 (38%) 
Smoking 140 (24%) 259 (27%) 103 (41%) 81 (32%) 
Alcohol (any) 126 (21%) 419 (44%) 133 (52%) 182 (73%) 
Hard Physical Activity 
hr/wk 
    
<1hr 561 (95%) 827 (88%) 212 (83%) 180 (72%) 
1hr 28 (5%) 133 (12%) 42 (17%) 70 (28%) 
Education 
    
 25
Junior high school 460 (78%) 575 (60%) 142 (56%) 111 (44%) 
Senior high school 108 (18%) 252 (26%) 87 (34%) 77 (31%) 
College/University 21 (4%) 133 (14%)      25 (10%) 62 (25%) 
* Differences between dead and alive for both genders are statistically significant at P<0.05, except for BMI 
** BMI, body mass index 
a Values represent mean (SD) for continuous variables 
b Values represent number (%) for categorical variables 
 
Table 2. Standardised by age mortality ratios (SMRs) and crude mortality rates according to 
gender, fracture type and different time intervals 
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Bolded rates are significant at p<0.05
Women Men 
Fracture type Person-years Deaths (n) Crude mortality 
rates/100 py (95% CI) 
SMR (95%CI)    Person-years Deaths (n) Crude mortality 


































































































































































































































































































































Table 3. Multivariable adjusted mortality risk following subsequent fracture by gender and 
initial fracture type in the fracture cohort 
 
*Adjusted for age, BMI, comorbidities, marital status, general health condition, education level, smoking, 



























































































































































Table 4. Impact of fractures on mortality by gender and fracture type 
*PIN= population impact number and their 95% confidence intervals, PIN is the number of those in the whole 
population amongst whom one death is attributable to fracture. 
*CIN= cases impact number and their 95% confidence intervals, CIN is the number of those who died amongst 
whom one case is attributable to fracture. 
 N/A= not applicable because distal fractures were not si 
  Women Men 
Fracture types PIN* CIN* PIN CIN 
Any fracture 373 (254-611) 10 (7-16) 449 (316-724) 15 (11-23) 










   -Proximal   1646 (960-3841) 42 (25-96) 2014 (1157-4410) 63 (37-136) 
   -Distal  N/A* N/A N/A N/A 
